dextrothyroxine has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alqallaf, SM; Evans, BA; Kidd, EJ | 1 |
| Crews, FT; Vetreno, RP; Zou, J | 1 |
2 other study(ies) available for dextrothyroxine and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
| Article | Year |
|---|---|
Atypical P2X receptor pharmacology in two human osteoblast-like cell lines.
Topics: Adenosine Triphosphate; Cell Line; Cell Membrane; Glycolysis; Humans; Immunohistochemistry; Immunoprecipitation; Ivermectin; Osteoblasts; Porosity; Protein Multimerization; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
ATP-P2X7 receptor signaling controls basal and TNFα-stimulated glial cell proliferation.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Animals, Newborn; Aquaporin 4; Bromodeoxyuridine; Calcium-Binding Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Entorhinal Cortex; Enzyme Inhibitors; Gene Knockout Techniques; Hippocampus; Ivermectin; Microfilament Proteins; Neuroglia; Organ Culture Techniques; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; RNA, Small Interfering; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2012 |